RecruitingPhase 2NCT07288034Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialSponsor: City of Hope Medical CenterZion, IL · +12 more sites
RecruitingPhase 3NCT06216301LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCSponsor: NovoCure GmbHBarrington, IL · Elmhurst, IL · Naperville, IL · +35 more sites
RecruitingPhase 1NCT07277413A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsSponsor: IDEAYA BiosciencesZion, IL · +22 more sites
RecruitingPhase 2 / Phase 3NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerSponsor: SWOG Cancer Research NetworkAlton, IL · Aurora, IL · +1226 more sites